The Single Best Strategy To Use For iMDK
All enrolled sufferers who been given not less than a person dose of zosuquidar or placebo in the course of induction were being monitored for your event of adverse gatherings (439 people, 219 on zosuquidar and 210 on placebo). The commonest adverse activities ended up connected to the duration of extended and sizeable myelosuppression as is antici